Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look like a treatment effect when it is just statistics.
Second pass at: Regression to the mean in progress reports posts 61–76
This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.
Absence of evidence and evidence of absence: if a study is small and finds no effect, that is absence of evidence, not evidence of absence. A larger study might find an effect that a small study missed.
Picking up post #61: that is the part I would want checked first.
Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the kind that comes from remembering a figure instead of looking it up.
Collapsed as off-topic by two members at trust level 3 or above
Power and sample size: a study might be too small to detect a real effect (low power). Sample size calculations help determine how many participants are needed to detect an effect of a given magnitude.
I read post #65 twice before replying, because I had assumed the opposite.
Regression to the mean: if you select people with extreme values (very high or very low), their next measurement is often less extreme just by chance. This can look like a treatment effect when it is just statistics.
This follows post #65 rather than contradicting it.
Confounding: a third variable explains an apparent association. In randomised data, randomisation balances confounders. In observational data, confounders can be adjusted for but unknown ones cannot.
post #69 answers the question as asked. The question underneath it is different.
P-values and significance: p<0.05 means the data would be surprising if the null hypothesis were true, not that the null hypothesis is false. A non-significant p-value does not mean "no effect".
Coming back to post #70, because the follow-up matters more than the original answer.
Relative risk and odds ratios: both compare the rate in one group to the rate in another. Relative risk is easier to understand. Odds ratios are standard in many analyses but can be misinterpreted.
Confidence intervals: rather than a single point estimate, a range of plausible values. A narrow interval means precise measurement; a wide interval means measurement is imprecise. Wider intervals (more uncertainty) are honest about limitation.
Multiplicity and multiple comparisons: if you test many hypotheses, the chance of finding a false positive by random chance increases. That is why pre-specifying the primary hypothesis matters.
I read post #74 twice before replying, because I had assumed the opposite.
Effect sizes: the magnitude of a difference, not just whether it is statistically significant. A difference that is significant (p<0.05) might be too small to matter. A large effect might not be significant if sample size is small.
This topic was referenced in
- [2026 update] Correlation in a self-tracked dataset: what it can supportResearch Methods › Statistics · 2 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
What a confidence interval means, from scratch — the long version
The question in the title: What a confidence interval means, from scratch — the long version I will give what I have already checked below so nobody repeats it. I have seen SURMOUNT-2 ( Lancet , 2023) cited…
|
+16 | 20 | 2.3k | 8mo |
|
Absence of evidence and evidence of absence
Absence of evidence and evidence of absence Writing it up because I had to work it out twice and would rather nobody else did. Session topic: SURMOUNT-OSA ( N Engl J Med , 2024). Please read it before…
|
+16 | 20 | 3.9k | 5mo |
|
Second pass at: Absence of evidence and evidence of absence
On the subject in the title: Second pass at: Absence of evidence and evidence of absence Working notes rather than a conclusion. Session topic: SELECT ( N Engl J Med , 2023). Please read it before posting;…
|
+50 | 55 | 18k | 16h |
|
Correlation in a self-tracked dataset: what it can support
Correlation in a self-tracked dataset: what it can support — setting out what I have, and where I think it stops being reliable. I have seen STEP 4 ( JAMA , 2021) cited in support of a claim I do not think it…
|
+152 | 166 | 48k | 23mo |
|
Multiplicity when you track fifteen variables
Multiplicity when you track fifteen variables — setting out what I have, and where I think it stops being reliable. Comparing LEADER ( N Engl J Med , 2016) with SURMOUNT-OSA ( N Engl J Med , 2024) and finding…
|
2 | 60k | 11mo |
Related topics — sharing the tags effect size, worked example, heterogeneity
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Dead volume across syringe and needle combinations
On the subject in the title: Dead volume across syringe and needle combinations Working notes rather than a conclusion. Practical question with the units stated, because I have seen how quickly these go wrong…
|
+72 | 80 | 28k | 5mo |
|
Prediction intervals and why they are more honest than confidence intervals
Posting this under the heading it deserves: Prediction intervals and why they are more honest than confidence intervals Everything below is what sits behind that. Comparing SURMOUNT-4 ( JAMA , 2024) with FLOW…
|
+21 | 25 | 46k | 4mo |
|
Comparing my trajectory with the trial curves, carefully
Posting this under the heading it deserves: Comparing my trajectory with the trial curves, carefully Everything below is what sits behind that. Maintenance rather than loss, which is the part of this that…
|
+86 | 92 | 54k | 7mo |
|
A critique that turned out to be unfair, retracted by its author
Posting this under the heading it deserves: A critique that turned out to be unfair, retracted by its author Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
|
+34 | 38 | 20k | 17h |
|
The "under review" status pill and when a moderator applies it
Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. Session topic: SURMOUNT-4 ( JAMA , 2024). Please read it…
|
+96 | 119 | 17k | 3mo |